Results 201 to 210 of about 1,771,252 (265)
RIPK4 function interferes with melanoma cell adhesion and metastasis
RIPK4 promotes melanoma growth and spread. RIPK4 levels increase as skin lesions progress to melanoma. CRISPR/Cas9‐mediated deletion of RIPK4 causes melanoma cells to form less compact spheroids, reduces their migratory and invasive abilities and limits tumour growth and dissemination in mouse models.
Norbert Wronski +9 more
wiley +1 more source
Augmented reality for advanced prosthetic training in non-amputees. [PDF]
Deus L, Wohlbach L, D'Andrea SE.
europepmc +1 more source
COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos +6 more
wiley +1 more source
Pre‐analytical handling critically determines liquid biopsy performance. This study defines practical best‐practice conditions for cell‐free DNA (cfDNA) and extracellular vesicle–derived DNA (evDNA), showing how processing time, storage conditions, tube type, and plasma input volume affect DNA integrity and mutation detection.
Jonas Dohmen +11 more
wiley +1 more source
High-throughput discovery and characterisation of pentafluorobenzene sulfonamide modifiers of Aurora A kinase. [PDF]
Chesti J +10 more
europepmc +1 more source
The Biological Significance of Calmodulin Binding to Lipids. [PDF]
O'Day DH.
europepmc +1 more source
Nested ecosystems theory for conceptualizing brain tumors.
Forster LA, Gutmann DH.
europepmc +1 more source
EMBO Press co-evolves with molecular ecology and evolutionary biology. [PDF]
Moran Y +13 more
europepmc +1 more source
Publisher Correction: SLC2A1<sup>+</sup> tumour-associated macrophages spatially control CD8<sup>+</sup> T cell function and drive resistance to immunotherapy in non-small-cell lung cancer. [PDF]
Wang L +20 more
europepmc +1 more source

